Skip to main content

An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A

Buy Article:

$48.00 plus tax (Refund Policy)

Abstract:

Objective 

To assess the accuracy of an automated blood pressure device (Microlife 3BTO-A) in pregnancy and pre-eclampsia according to the British Hypertension Society (BHS) protocol. Design 

Prospective observational study. Setting 

Antenatal ward and clinics at Guy's and St Thomas' Hospital, London, UK. Population 

One hundred and five pregnant women including 35 women with non-proteinuric hypertension and 35 with pre-eclampsia. Methods 

Two trained observers took nine sequential same-arm measurements from each woman. Measurements alternated between a mercury sphygmomanometer and the device. Main outcome measures 

Grading criteria of the BHS protocol (A/B grade = pass; C/D grade = fail). Results 

The device passed the BHS protocol by achieving an A/B grade. It also achieved criteria of the Association for the Advancement of Medical Instrumentation for systolic and diastolic pressures respectively, in normotensive [−0.5 (5.7) mmHg; −0.07 (7.7) mmHg], non-proteinuric hypertensive [−3.3 (6.9) mmHg; −2.4 (6.6) mmHg] and pre-eclamptic pregnancy [−4.1 (6.4) mmHg; −1.3 (7.9) mmHg]. Conclusion 

The Microlife 3BTO-A can be recommended for use in a pregnant population, including pre-eclampsia, according to the BHS protocol.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1471-0528.2005.00617.x

Publication date: July 1, 2005

bsc/bjo/2005/00000112/00000007/art00012
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more